Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition

NCT01582217 · clinicaltrials.gov ↗

COMPLETED

Status

318

Enrollment

OTHER

Sponsor class

Conditions

Percutaneous Coronary Intervention
Dual Antiplatelet Therapy
Aspirin
Clopidogrel

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]
[object Object]